The role of molecular genetic factors in the development of the first episode and recurrent noncardioembolic ischemic stroke

Cover Page

Cite item

Full Text

Abstract

Aim. To assess the polymorphic allele distribution of the APO A5 (rs34282181), APO A5 (rs619054), APO E (rs5174), APO C4 (rs1132899), APO H (rs4581), LPL (rs199675233), LP (a) (rs41267) genes B (rs1042031), APO B (rs676210), APO D (rs7659), ANGPT4 (rs1044250), TNF-а (rs1800620), VEGFA (rs62401172), IL8 (rs1803205), IL6 (rs56383910), MTH1801131), ADIPOQ-AS1 (rs17366743), ADIPOQ-AS1 (rs185847354), ADIPOR2 (rs12342), GRM 1 (rs1047005), GRM 3 (rs2228595), BDNF (rs6265) genes to reveal the association with the development of the first episode and recurrent noncardioembolic ischemic stroke (IS). Materials and methods. As part of the study, conducted in two stages, where the first stage is a case-control study and the second is an observational cohort study, we identified 23 variants of single-nucleotide polymorphisms in 206 patients who had the first episode of noncardioembolic IS and in 206 sex-, age- and residence-matched healthy volunteer. Polymorphisms genotyping was performed with ready-to-use TaqMan probes. Results. For single-nucleotide polymorphic variants of the ADIPOQ-AS1 (rs17366743), APO B (rs676210), APO A5 (rs619054), APO D (rs7659) and IL8 (rs1803205) genes, an association with the development of first episode of noncardioembolic IS was established. For the single-nucleotide polymorphic variant of the ADIPOR2 (rs12342) gene, an association with the protection against the development of recurrent noncardioembolic ischemic stroke was established. Conclusion. Significant associations for single-nucleotide polymorphic variants of genes with the development of first episode and recurrent noncardioembolic IS were found.

About the authors

Veronika N. Shishkova

Center for Speech Pathology and Neurorehabilitation; Yevdokimov Moscow State University of Medicine and Dentistry

Email: veronika-1306@mail.ru
канд. мед. наук, ст. науч. сотр., врач-эндокринолог Moscow, Russia

Tatiana V. Adasheva

Yevdokimov Moscow State University of Medicine and Dentistry

д-р мед. наук, проф. каф. поликлинической терапии Moscow, Russia

Liudmila V. Stakhovskaia

Pirogov Russian National Research Medical University

д-р мед. наук, проф. каф. неврологии, нейрохирургии и медицинской генетики Moscow, Russia

Alla Iu. Remennik

Center for Speech Pathology and Neurorehabilitation

канд. мед. наук, зав. клинико-биохимической лаб Moscow, Russia

Vera V. Valiaeva

Center for Speech Pathology and Neurorehabilitation

врач-лаборант клинико-биохимической лаб Moscow, Russia

References

  1. Стаховская Л.В., Котов С.В., Исакова Е.В. Инсульт: руководство для врачей. М.: Медицинское информационное агентство, 2013.
  2. Adams HP, Bendixen BH, Kappelle J et al. Classification of subtype of acute ischemic stroke. Stroke 1993: 24 (1); 35-41.
  3. Скворцова В.И., Шетова И.М., Шамалов Н.А. и др. Анализ ассоциации ДНК-маркеров с риском развития церебрального инсульта у лиц из славянской популяции. Вестник Российского государственного медицинского университета. 2011; 6: 62-6.
  4. Торшин И.Ю., Громова О.А., Никонов А.А. Гены и цереброваскулярная патология, гены и нуклеотидные полиморфизмы при отдельных видах физиологических сдвигов и патологических процессов. Журн. неврологии и психиатрии (Прил. «Инсульт»). 2009; 5: 77-83.
  5. Fornage M. Genetics of stroke. Curr Atheroscler Rep 2009; 11: 167-74.
  6. Ikram MA, Seshadri S, Bis JC et al. Genome wide association studies of stroke. N Eng J Med 2009; 360 (17): 1718-28.
  7. Malik R, Traylor M, Pulit SL. Low-frequency and common genetic variation in ischemic stroke: the METASTROKE collaboration. Nature 2016; 86 (13): 1217-26.
  8. Шишкова В.Н., Адашева Т.В., Ременник А.Ю. и др. Изучение ассоциаций полиморфных вариантов генов липидного и углеводного обменов, сосудистого воспаления и нейротрансмиттерных систем с развитием первого ишемического инсульта. Кардиоваскулярная терапия и профилактика. 2017; 16 (5): 27-31.
  9. Hixson JE, Vernier DT Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31 (3): 545-8.
  10. Ньюссбаум Р.Л., Мак-Иннес Р.Р., Виллард Х.Ф. Медицинская генетика: учеб. пособие. М.: ГЭОТАР-Медиа, 2010.
  11. Кошечкин В.А., Рожкова Т.А., Малышев П.П. Практическая липидология с методами медицинской генетики. Руководство. М.: ГЭОТАР-Медиа, 2019.
  12. Wang Y, Liu F, Li L et al. The association between apolipoprotein A1-C3-A5 gene cluster promoter polymorphisms and risk of ischemic stroke in the northern Chinese Han population. J Int Med Res 2017; 45 (6): 2042-52.
  13. Kucherenko AM, Shulzhenko DV, Kuznetsova SM et al. Association of IL8 and IL10 gene allelic variants with ischemic stroke risk and prognosis. Biopolym Cell 2014; 30 (3): 234-8.
  14. Шишкова В.Н., Адашева Т.В., Ременник А.Ю. Прогностическая значимость клинико-антропометрических, биохимических, метаболических, сосудисто-воспалительных и молекулярно-генетических маркеров в развитии первого ишемического инсульта. Журн. неврологии и психиатрии им. С.С. Корсакова. 2018; 118 (2): 4-11.
  15. Zhu R, Zhao Y, Xiao T et al. Association between microRNA binding site polymorphisms in im-munoinflammatory genes and recurrence risk of ischemic stroke. Genomics 2020; 112 (3): 2241-6.

Copyright (c) 2020 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies